Related references
Note: Only part of the references are listed.Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
Rajesh K. Sharma et al.
CANCER RESEARCH (2009)
The role of TNF superfamily members in T-cell function and diseases
Michael Croft
NATURE REVIEWS IMMUNOLOGY (2009)
Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma
Oihana Murillo et al.
CLINICAL CANCER RESEARCH (2008)
Targeting tumors with LIGHT to generate metastasis-clearing immunity
Ping Yu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways
Carl F. Ware
IMMUNOLOGICAL REVIEWS (2008)
Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous Fas Ligand protein
Esma S. Yolcu et al.
JOURNAL OF IMMUNOLOGY (2008)
Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling
Kutlu G. Elpek et al.
JOURNAL OF IMMUNOLOGY (2007)
LIGHT is critical for IL-12 production by dendritic cells, optimal CD4+ th1 cell response, and resistance to leishmania major
Guilian Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas
Richard C. E. Anderson et al.
NEUROSURGERY (2007)
CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model
Kutlu G. Elpek et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors
Nan Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon
Mehmet O. Kilinc et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo
NP Singh et al.
HUMAN GENE THERAPY (2006)
NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors
ZS Fan et al.
BLOOD (2006)
LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM
Sook-Kyoung Heo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Eradication of established tumors in mice by a combination antibody-based therapy
Tomoyasu Uno et al.
NATURE MEDICINE (2006)
Neuroblastoma cells transiently transfected to simultaneously express the co-stimulatory molecules CD54, CD80, CD86, and CD137L generate antitumor immunity in mice
BD Johnson et al.
JOURNAL OF IMMUNOTHERAPY (2005)
A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo
B Gückel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Priming of naive T cells inside tumors leads to eradication of established tumors
P Yu et al.
NATURE IMMUNOLOGY (2004)
The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients
GM Zou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Ligation of CD 137 receptor prevents and reverses established anergy of CD8(+) cytolytic T lymphocytes in vivo
RA Wilcox et al.
BLOOD (2004)
Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection
ES Yolcu et al.
IMMUNITY (2002)
Cutting edge: expression of functional CD137 receptor by dendritic cells
RA Wilcox et al.
JOURNAL OF IMMUNOLOGY (2002)
Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection
EM Bertram et al.
JOURNAL OF IMMUNOLOGY (2002)
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
RA Wilcox et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Local costimulation reinvigorates tumor-specific cytolytic T lymphocytes for experimental therapy in mice with large tumor burdens
XF Bai et al.
JOURNAL OF IMMUNOLOGY (2001)
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity
Y Morel et al.
JOURNAL OF IMMUNOLOGY (2001)
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
EM Sotomayor et al.
BLOOD (2001)
Share Paper
